https://scholars.lib.ntu.edu.tw/handle/123456789/465717
標題: | Panitumumab-Conjugated and Platinum-Cored pH-Sensitive Apoferritin Nanocages for Colorectal Cancer-Targeted Therapy | 作者: | Lin C.-Y. Yang S.-J. Peng C.-L. MING-JIUM SHIEH |
關鍵字: | apoferritin; colorectal cancer; EGFR; oxaliplatin; panitumumab | 公開日期: | 2018 | 出版社: | American Chemical Society | 卷: | 10 | 期: | 7 | 起(迄)頁: | 6096-6106 | 來源出版物: | ACS Applied Materials and Interfaces | 摘要: | Apoferritin (AF) is a natural nontoxic iron carrier and has a natural hollow structure that can be used to deliver small molecules. The surface of AF has many amine functional groups that can be modified to create targeted ligands. We loaded oxaliplatin onto AF, which was then used as a template to conjugate with panitumumab via a polyethylene glycol linker. The oxaliplatin-loaded AF conjugated with panitumumab (AFPO) was designed to specifically target cell lines expressing epidermal growth factor receptor (EGFR). AFPO efficiently released oxaliplatin and suppressed tumor cell growth. Furthermore, the novel AFPO nanocages showed significant inhibition and greater accumulation in tumor models with high EGFR expression in vivo. Our study revealed that combining panitumumab and oxaliplatin into one formulation (AFPO nanocage) could be a promising shortcut in clinical applications. ? 2018 American Chemical Society. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042527318&doi=10.1021%2facsami.7b13431&partnerID=40&md5=edac65286c7dfddc45ab2b0406a49d77 https://scholars.lib.ntu.edu.tw/handle/123456789/465717 |
ISSN: | 1944-8244 | DOI: | 10.1021/acsami.7b13431 | SDG/關鍵字: | Cell culture; Cell growth; Tumors; Apoferritin; Colorectal cancer; EGFR; Oxaliplatin; panitumumab; Diseases; apoferritin; epidermal growth factor receptor; panitumumab; platinum; chemistry; colorectal tumor; human; pH; Apoferritins; Colorectal Neoplasms; ErbB Receptors; Humans; Hydrogen-Ion Concentration; Panitumumab; Platinum |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。